LDL cholesterol target attainment in cardiovascular high- and very-high-risk patients with statin intolerance: a

Julius L Katzmann1, Paulina E Stürzebecher2, Silvia Kruppert3

  • 1Klinik und Poliklinik für Kardiologie, Universitätsklinikum Leipzig, Leipzig, Germany. julius.katzmann@medizin.uni-leipzig.de.

Scientific Reports
|January 3, 2024
PubMed

Insights

Statin intolerance (SI) hinders LDL-C target achievement. Alternative therapies like ezetimibe and bempedoic acid significantly increase the likelihood of reaching lipid goals in high-risk patients with SI.

Area of Science:

  • Cardiology
  • Pharmacology
  • Public Health

Background:

  • Statin intolerance (SI) is a significant barrier to achieving guideline-recommended low-density lipoprotein cholesterol (LDL-C) targets.
  • Patients experiencing SI necessitate alternative lipid-lowering therapies (LLT) to manage hypercholesterolemia and reduce cardiovascular risk.
  • Electronic medical records (EMR) provide valuable data for defining and analyzing patient populations with SI.

Purpose of the Study:

  • To simulate LDL-C target achievement using oral LLT (ezetimibe, bempedoic acid) in patients with SI.
  • To assess the effectiveness of ezetimibe and bempedoic acid as monotherapies and in combination for SI patients.
  • To evaluate the proportion of high and very-high cardiovascular risk patients achieving LDL-C targets with alternative LLT.

Main Methods:

  • A simulation study utilizing representative data from 2.06 million German outpatients.
  • SI was defined using literature-informed criteria applied to EMR data.
  • LDL-C target achievement was simulated with stepwise addition of ezetimibe and bempedoic acid in patients with hypercholesterolemia and high/very-high cardiovascular risk.

Main Results:

  • 8.6% of 130,778 eligible patients met the SI definition; only 7.7% achieved LDL-C targets at baseline.
  • Simulated treatment with ezetimibe and bempedoic acid increased LDL-C target achievement to 22.6% and 52.0%, respectively.
  • Combination therapy with ezetimibe and bempedoic acid demonstrated substantial potential for increasing LDL-C reductions in SI patients.

Conclusions:

  • Oral LLT, including ezetimibe and bempedoic acid, can significantly improve LDL-C target attainment in patients with SI and high cardiovascular risk.
  • The combination of ezetimibe and bempedoic acid offers a promising strategy for managing hypercholesterolemia in patients intolerant to statins.
  • These findings highlight the importance of alternative LLT in achieving cardiovascular risk reduction goals for patients with SI.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
665
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
164
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
551
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
745
Rational Dosage Regimen: Maintenance Dose and Loading Dose01:24

Rational Dosage Regimen: Maintenance Dose and Loading Dose

A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
4.1K